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background: Moderate to severe bleeding is one of the most common adverse events after catheter ablation of atrial fibrillation (CAAF) 
(2.2%). Limited data are available about the use of vascular closure device (VCD) for venous accesses without reversal of anticoagulation.
Methods:  Medical records of patients who underwent CAAF were reviewed. In the standard hemostasis protocol, venous sheathes 
were removed when ACT was ≤ 200 seconds and manual pressure was applied for 15 minutes. Ambulation was permitted in 4 hours 
and heparin could be started in 6 hours. In the VCD protocol, a suture-mediated VCD was applied to each access site regardless of 
ACT level. Ambulation was permitted in 2 hours. Minor bleeding was controlled with manual compression. Moderate bleeding required 
blood transfusion ≤ 4 units, surgical intervention or drop in hemoglobin ≥ 3 gm/dL. Severe bleeding included emergency surgery, blood 
transfusion > 4 units or death.
results:  Between 2010 and 2013, VCD were used in 204 cases of CAAF with 761 vascular accesses. VCD deployments were 
unsuccessful in 1.1% of cases. Outcomes were compared to the standard protocol in matched control subjects. There was no significant 
difference in vascular or non-vascular bleeding or hospital stay (Table). One case of severe bleeding was secondary to arterial injury. There 
were no mortalities, vein thrombosis or major non-vascular bleeding.
Conclusion:  VCDs were not associated with a significant reduction in the risk of vascular bleeding compared to manual compression.
Vascular closure versus manual compression protocol
Standard protocol
(242 accesses in 62 cases)
Closure device
(761 accesses in 204) P value
Age; years 59.8 ± 7.7 60.9 ± 10.6 0.39
Gender; Male (%) 74.2% 75% 0.96
BMI (kg/m2) 33.3 ± 8.9 31.3 ± 6.4 0.09
ACT seconds 190.8 ± 37.6 309.0 ± 58.3 < 0.0001
INR 1.26 ± 0.38 1.55 ± 0.6 < 0.0001
Minor bleeding 12.9% 13.7% 0.96
Moderate bleeding 1.6% 1.96% 0.72
Hospital stay, days (median) 1.22 1 0.08
Drop in hemoglobin (gm/dl) 2.05 ± 1.4 1.9 ± 1 0.45
